Carbonyl reduction of aldehydes, ketones and quinines to their corresponding hydroxyl derivates plays an important role in the phase I metabolism of many endogenous and xenobiotics compounds; carbonyl reduction has been shown to be of significance in various inactivation processes of drugs bearing a carbonyl group